Obesity blunts catecholamine and growth hormone responses to exercise in adults, but the effect of obesity on these exercise-associated hormonal responses in children is unclear. Therefore, the aim of the present study was to asses the effect of childhood obesity on the counter-regulatory hormonal response to acute exercise. Twenty-five obese children (Ob, BMI> 95%), and 25 age, gender and maturity matched normal weight controls (NW) participated in the study. Exercise consisted of ten two-min bouts of constant cycle-ergometry above the anaerobic threshold, with one-min rest intervals between each bout. Pre, post and 120-min post exercise blood samples were collected for circulating components of the GH-IGF-I axis and catecholamines. There were no differences in peak exercise heart rate, serum lactate and peak VO 2 normalized to lean body mass between the groups. Obesity attenuated the GH response to exercise (8.9±1.1 versus 3.4±0.7 ng/ml in NW and Ob participants, respectively; p<0.02). No significant differences in the response to exercise were found for other components of the GH-IGF-I axis. Obesity attenuated the catecholamine response to exercise (epinephrine: 52.5±12.7 versus 18.7±3.7 pg/ml, p<0.02; norepinephrine: 479.5±109.9 versus 218.0±26.0 pg/ml, p<0.04; dopamine: 17.2±2.9 versus 3.5±1.9 pg/ml, p<0.006 in NW and Ob, respectively). Insulin levels were significantly higher in the obese children, and dropped significantly after exercise in both groups. Despite the elevated insulin levels and the blunted counter-regulatory response, none of the participants developed hypoglycemia. Childhood obesity was associated with attenuated GH and catecholamine response to acute exercise. These abnormalities were compensated for, so that exercise was not associated with hypoglycemia despite increased insulin levels in obese children.
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Measurement of fitness
Each subject performed a cycle ergometer ramp-type progressive exercise test to the limit of his/her tolerance. Subjects were vigorously encouraged during the highintensity phases of the exercise protocol. Gas exchange was measured breath-by-breath and the anaerobic (ventilatory/lactate) threshold, respiratory exchange ratio (RER) and peak VO 2 were calculated using a Sensor Medics metabolic system (7) .
Exercise protocol
Exercise consisted of 10 two-minutes bouts of constant work rate cycle ergometry, with one minute rest interval between each of the 10 bouts of exercise. The work rate was individualized for each child and was calculated to be equivalent to the work rate corresponding to 50% between the ventilatory/lactate threshold (as determined non-invasively from the ramp-type test) and the peak VO 2 . We have used this protocol in the past in order to ensure that the exercise input was standardized to physiological indicators of each subject's exercise capacity (42) . The total duration of the exercise session is 30 minutes (20 minutes cycling interspersed by 10 minutes resting)
Blood Sampling and analysis
Morning (following an overnight fast) pre, immediately post and 120 min post exercise (recovery) blood samples were drawn from an indwelling venous catheter that was inserted 30 minutes prior to the first blood draw. Blood samples were immediately spun at 3000 rpm, at 4ºC for 20 minutes. The serum was separated and stored at 80ºC.
All pre and post exercise specimens from each individual were analyzed in the same batch by an experienced technician who was blinded to the individual's group (normal weight versus obese), and to the order of samples.
Growth Hormone. GH serum concentrations were determined by ELISA with the use of the DSL-10-1900 Active kit (Diagnostic System Laboratories, Webster, Texas). Intraby 10.220.33.6 on October 1, 2017 http://jap.physiology.org/ Downloaded from assay CV was 3.3-4.5%, inter-assay CV was 5.5-12.9%, and the sensitivity was 0.03 ng/ml.
Growth Hormone Binding Protein. GHBP serum levels were measured using ELISA with the use of the DSL-10-4800 Active kit (Diagnostic Systems Laboratories, Webster, TX).
Intra-assay CV was 3.2-5.6%, inter-assay CV was 5.0-8.0%. Assay sensitivity was 1.69 pmol/L.
Insulin-like Growh Factor-I: total and free. IGF-I was extracted from IGF-binding proteins (IGFBPs) by using the acid-ethanol extraction method (9) . Serum IGF-I concentrations were determined by a two-site immunoradiometric assay by using the DSL-5600 Active kit (Diagnostic System Laboratories, Webster, TX). IGF-I intra-assay CV was 1.5-3.4% and the inter-assay CV was 3.7-8.2%. Assay sensitivity was 0.8 ng/ml. Free IGF-I was determined by ELISA with the use of the DSL-10-9400 Active kit (Diagnostic System Laboratories). Intra-assay CV was 3.74-4.8%, inter-assay CV was 6.2-11.1%, and the sensitivity was 0.015 ng/ml.
IGF Binding
Proteins. IGFBP-1 was measured by a coated-tube immunoradiometric assay with the use of the DSL-10-7800 Active kit (Diagnostic System Laboratories).
Intra-assay CV was 2-4%, and inter-assay CV was 1.7-6.7%. Assay sensitivity is 0.33 ng/ml. IGFBP-2 serum concentrations were determined by RIA with the use of the DSL-7100 kit (Diagnostic System Laboratories). Intra-assay CV was 4.7-8.5%, inter-assay CV was 7.2-7.4%, and the sensitivity was 0.5 ng/ml. IGFBP-3 serum concentrations were determined by ELISA with the use of the DSL 10-6600 Active kit (Diagnostic System Laboratories). Intra-assay CV was 7.3-9.6%, inter-assay CV was 8.2-11.4%, and the sensitivity was 0.04 ng/ml. IGFBP-4 serum concentrations were determined by ELISA with the use of the DSL 10-7300 Active kit (Diagnostic System Laboratories). Intra-assay CV was 2.8-6.4%, inter-assay CV was 2.3-6.7%, and the sensitivity was 1 ng/ml. Lactate. Serum lactate was measured spectrophotometrically (YSI 1500, Yellow Springs, OH). Intra-assay CV was 2.8%, inter-assay CV was 3.5%, and the sensitivity was 0.2 mg/dl.
Glucose. Serum glucose levels were determined by YSI 2300 STAT Plus analyzer. The assay precision is ±2.0% or 2.5mg/L (the higher value of the two).
Insulin. Serum insulin levels were determined by ELISA with the use of the DSL-10-1600
Active kit (Diagnostic System Laboratories). Intra-assay CV was 1.3-2.6%, inter-assay CV was 5.2-6.2%, and the sensitivity was 0.26 SIU/ml.
Cortisol. Serum cortisol levels were determined by a commercial RIA (Diagnostic Products Corporation, Los Angeles, CA). The intra and inter assay CV for this assay were 3.2% and 6.8% respectively.
Epinephrine, Norepinephrine,, and Dopamine. These catecholamines were measured by a radioenzymatic technique based on the conversion of the catecholamine to radiolabeled metanephrine and normetanephrine. This catecholamine assay uses an extraction technique that eliminates substances that may inhibit the radioenzymatic assay, and concentrates the catecholamine to provide a more sensitive assay. Plasma samples of one ml were extracted and then concentrated into a 0.1ml volume before conversion into the radio-labeled metabolites. The assay has an extraction efficiency of 78%. The sensitivity of the assay is 10 and 6 pg/mL for NE and EPI. The intra-assay CV are 4 and 13% for samples containing low levels of catecholamine; variation is less for samples with high levels of catecholamine. The inter-assay CV are 10% and 16%, respectively, for NE and EPI, so the assay is consistent over time. This technique is approximately 10 times more sensitive than the more commonly used assays and thus can reveal changes in venous catecholamine levels that often go undetected (20) . 
Statistical analysis
Unpaired t-tests were used for baseline comparison between obese and normal weight children. Exploratory mixed-model ANOVA was used to assess the effect of exercise on the circulating components of the GH-IGF-I axis, catecholamines, cortisol, lactate, glucose and insulin with time (pre, post, and recovery) serving as the within group factor and BMI (normal range vs. obese) as the between group factor. In addition, simple correlations were computed between changes in the GH-IGF-I axis and body fat, lean body mass, peak aerobic power and changes in catecholamine levels. Data are presented as mean ± SEM. Significance was taken at p<0.05. 
Results
Anthropometric and Fitness Data.
Characteristics of the study participants are summarized in table 1. Body weight, BMI, BMI percentile, body fat and lean body mass were significantly higher in the obese children. Fitness as expressed by peak VO 2 normalized to body weight was significantly lower in the obese children. There were no differences between normal weight and obese children in peak exercise heart rate, peak exercise serum lactate levels and peak VO 2 normalized to lean body mass (figure 1). There was no difference in the respiratory exchange ratio between normal weight and obese children (1.07±0.01 versus 1.09±0.02 in normal weight and obese participants, respectively).
GH, GHBP, IGF-1, and IGFBP-3 and 4 (Table 2, Figure 2)
Baseline-GHBP was significantly greater in obese compared with normal-weight participants. No significant differences were noted at baseline for GH, total and free IGF-I, and IGFBP-3 and -4.
Exercise-GHBP was unchanged by exercise in both groups. GH increased significantly in both groups. However, the magnitude of the GH increase was significantly smaller in the obese children. Total IGF-I (but not free) increased significantly following exercise only in obese subjects. No significant exercise-induced change in IGFBP 3 and 4 was found between the groups.
Exercise-associated changes in GH levels were inversely correlated with BMI percentile, and body fat. No significant correlations were found between the GH response to exercise and insulin or IGF-I levels (Table 3) .
Catecholamines (Figure 3)
Baseline. There were no significant baseline differences between the groups in epinephrine, norepinephrine, or dopamine levels.
Exercise. Epinephrine and norepinephrine increased significantly in both obese and normal-weight subjects. However, the magnitude of the increase was significantly smaller in the obese subjects. While dopamine increased in the normal weight children, no significant increase in dopamine was found in obese subjects.
There was a significant correlation between fitness and the exercise-associated changes in catecholamines (Table 3 ). There was an inverse correlation between BMI percentiles and percent body fat and the exercise-associated changes in catecholamines (Table 3 ). There was a significant correlation between exerciseassociated changes in epinephrine and GH among the participants (r= 0.35, p<0.01).
Glucoregulation (glucose, insulin, cortisol, IGFBP-1 and 2; Table 2 and Figure 4).
Baseline. Insulin was significantly higher in obese compared with normal-weight subjects. IGFBP-1 and -2 were significantly lower in the obese subjects. Glucose and cortisol did not differ between the two groups.
Exercise. Insulin was reduced by exercise in both groups and remained lower through the recovery period. Although the pattern of the exercise effect was similar, insulin levels were significantly higher in the obese subjects. IGFBP-1 was significantly reduced by exercise in both groups, and there was no difference in the magnitude of the reduction between the groups. Glucose, cortisol, and IGFBP-2 were not affected by exercise in either group.
Discussion
To our knowledge, there have been few studies of GH response to exercise in children (15; 39; 48) and none in which both key GH IGF-I regulatory elements as well as neuroadrenergic factors were measured simultaneously. We found that both GH IGF axis hormones and neuroadrenergic hormones were influenced by obesity either at baseline and/or in response to exercise. The major finding of this study was that in obese children and adolescents, the GH and catecholamine responses to exercise were substantially attenuated (Figure 2 and 3) .
This study highlighted a number of possible mechanisms for the observed blunted GH response to exercise in obese children. First, the lower GH response in the obese children, whose fitness levels are generally lower than normal weight children (10) , cannot be attributed to a smaller magnitude of the exercise stress. This is relevant because when work is performed above the subjects LAT (heavy exercise, as was done in the present study), relatively small changes in the exercise input can lead to large differences in the response of hormones like GH and catecholamines (14) . The similar peak heart rate, respiratory exchange ratio, serum lactate levels and peak VO 2 normalized to lean body mass of the participants (Figure 1 ) indicate that we were able to achieve virtually identical metabolic and cardiovascular responses in the maximal exercise test in the two groups. As a consequence, the relative intensity of the interval exercise session was also similar in the two groups.
Increased insulin levels and increased IGF-I levels have also been suggested as possible causes for the reduced GH response to exercise in obese individuals (19) .
The mechanism of these effects is not fully understood but could be related to down regulation of GH cellular receptors by insulin and IGF-I (23). Consistent with this, baseline insulin levels were significantly higher in the obese children in the present study. Moreover, insulin in obese subjects remained higher even though insulin With regards to IGF-I, there was no significant difference in pre-exercise free or total IGF-I between normal-weight and obese subjects. IGF-I levels increased acutely with exercise in the obese subjects [by about 15%, an observation made in healthy subjects previously (4; 38)], although the increase in IGF-I in the normal weight children was not significant. Similar to insulin, no correlations were found between IGF-I levels (total and free) and the change in the GH response to exercise. Collectively, the data suggests the possibility that the exercise associated increase in circulating IGF-I levels could play a partial role in the blunted GH response observed in the obese children and adolescents.
In addition, our data do support the idea that the attenuated GH response to exercise is related to an obesity-associated generalized impairment of the adrenergic response to exercise as was suggested by Vettor et al (45) . Although epinephrine and norepinephrine increased significantly in both the obese and control subjects, the magnitude of the increase was significantly lower in the obese children. While circulating dopamine increased in normal-weight children, no significant increase in dopamine was observed in obesity ( Figure 3 ). In addition, exercise associated changes in GH levels were significantly correlated with changes in epinephrine. norepinephrine and, to a lesser degree, dopamine release, from nerve endings into the circulation (32; 43). Thus, exercise shares with other stresses (e.g., psychosocial) some common pathways leading to increased catecholamine output (49) . In addition, the catecholamine response to heavy exercise is further stimulated by systemic changes in acid-base balance and reduced oxygen availability to the working tissues (37) .
Remarkably, the increase in circulating dopamine in response to exercise found in healthy children was absent in obese children and adolescents (Figure 3 ). Previous studies have demonstrated an increase in circulating dopamine in response to cycle ergometer (29) and resistance exercise (21) in adults, as well as in healthy children (47) .
Whether the lack of a peripheral dopamine response in obesity is related to a systemic "dopamine deficit" (25; 46), or, alternatively, simply to less stimulation of the sympathetic system in response to exercise, has yet to be determined.
There are growing data that blunting central neuroadrenergic pathways can simultaneously attenuate the GH and catecholamine arms of the global stress response.
For example, Giordano et al. (16) showed that alprazolam (a benzodiazepine that activates GABA receptors in the brain) inhibited both the GH and catecholamine response to insulin-induced hypoglycemia, and previous studies have shown that benzodiazepines inhibit the catecholamine response to exercise as well (41) . Reduced central dopaminergic tone could explain our findings of blunted catecholamines and GH in response to exercise in obese subjects. There are indirect data suggesting that dopamine-2 receptor (D2) gene may be abnormal in obese subjects (34) , and this could lead to reduced central dopaminergic tone.
Intriguingly, we recently demonstrated a virtually identical pattern of blunted catecholamine responses to exercise in normal weight children with attention deficit hyperactivity disorder (ADHD) (n.b., we did not measure GH) (47) . Surprisingly, despite the common belief that children with ADHD are physically hyperactive during early There were no differences in the response to exercise of the other components of the GH-IGF-I axis that we chose to measure (i.e. GHBP, IGF-I, free IGF-I and IGFBP's). Several investigators [e.g. Kanaley and coworkers (19) ] speculated that the beneficial effects of exercise in obese subjects might be limited due to the suppressed GH response to exercise. However, it is now well established that many of the health effects of exercise training are mediated by IGF-I, and are GH independent (11; 50).
Despite the reduced GH response to exercise in obese subjects, levels of total IGF-I did not differ between the two groups (perhaps because of significantly greater GHBP), and IGF-I increased significantly with exercise only in the obese subjects. Thus, the attenuated GH response to exercise in obesity appears to be compensated by other hormonal mechanisms. These results also suggest that a limited effect of exercise interventions might be found in a subgroup of obese children with low baseline IGF-I levels and low IGF-I response to exercise [such as seen for example in obese children with Prader-Willi syndrome (44) ]. This group may possibly benefit from an intensive therapy of both exercise and exogenous GH. We also found marked effects of obesity on circulating IGFBP-1 and 2. These binding proteins are elevated in catabolic states, tend to antagonize IGF-I physiological function, and contribute to the bioavailability of IGF-I in tissues (35) . Circulating levels of both IGFBP-1 and -2 are inversely related to insulin levels, and, consequently, have been found to be low in obese adults and children (2; 3; 12), consistent with our data.
Insulin levels decreased following exercise, thus, we expected that both IGFBP-1 and -2 would increase. In fact, IGFBP-2 was not significantly affected by exercise while IGFBP-1 significantly decreased (concomitantly with insulin) in both groups. Why the exercise response for both insulin and IGFBP-1 were parallel and not inverse in the present study is not clear.
As noted, pre-and post exercise insulin levels were significantly elevated in the obese children. The combination of hyperinsulinemia with suppressed GH and catecholamine responses, both counterregulatory hormones, could potentially set the stage for increased risk of hypoglycemia during and after exercise. In fact, none of the participants in our study developed hypoglycemia. Apparently, the counterregulatory hormonal response to hypoglycemia is sufficiently robust and redundant in obese children such that hypoglycemia does not occur in response to exercise despite the increased glucose demand and the attenuated GH and catecholamine responses.
Conclusion
In response to a metabolically matched exercise-input, the GH response to exercise was reduced in obese children and adolescents. This likely resulted in part from changes in IGF-I levels and from baseline hyperinsulinemia found in the obese subjects. In addition, the reduced epinephrine and norepinephrine and the absent dopamine response to exercise in obese subjects suggested the possibility of a centrally mediated attenuation of hypothalamic-pituitary-adrenal axis and/or sympathetic adrenalmedullary function. It is possible that the blunted GH and catecholamine response to exercise lead to reduced carbohydrate and fat utilization during exercise (5; 6), and as a result to a greater protein utilization (26). Consistent with this, previous studies have demonstrated that elevated BMI was associated with a reduced training effect in children and adolescents following a prolonged resistance training intervention (13) .
The reduced GH and catecholamine responses to exercise were compensated for such that hypoglycemia did not occur with exercise despite increased insulin levels in the obese children and adolescents. Thus, these results support the use of exercise, even vigorous exercise, as part of the treatment regimen for obese children. Further studies are needed to clarify the mechanistic role of IGF-I, hyperinsulinemia and the reduced catecholamine response (in particularly dopamine) for the diminished exerciseassociated GH response, and the extent to which these hormonal abnormalities persist after weight loss and/or exercise training programs in obese children and adolescents. 
